Matinas BioPharma Provides Corporate Update and Reports First Quarter 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. PRY:IM
5. PRYMY
6. SKA-B
7. PBA
8. CCH:LN
9. META
10. CCHGY

Go back to Matinas BioPharma Provides Corporate Update and Reports First Quarter 2019 Financial Results

Matinas BioPharma (MTNB) Misses Q1 EPS by 1c

May 14, 2019 7:07 AM EDT

Matinas BioPharma (NYSE: MTNB) reported Q1 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $0 versus the consensus estimate of $30 thousand.

Throughout the first quarter, we made great progress across all aspects of our business, while adding impactful clinical and financial expertise to our management team. Most importantly, we closed... More